PMC:7594251 / 83620-83962
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T162 | 278-285 | Body_part | denotes | alanine | http://purl.org/sig/ont/fma/fma82749 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T85 | 189-192 | Disease | denotes | ADC | http://purl.obolibrary.org/obo/MONDO_0020689 |
| T86 | 329-341 | Disease | denotes | tuberculosis | http://purl.obolibrary.org/obo/MONDO_0018076 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T609 | 17-18 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T59537 | 37-41 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T77020 | 131-135 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T83203 | 141-151 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T23728 | 189-192 | Chemical | denotes | ADC | http://purl.obolibrary.org/obo/CHEBI_18198|http://purl.obolibrary.org/obo/CHEBI_35181 |
| T91597 | 243-254 | Chemical | denotes | L-aspartate | http://purl.obolibrary.org/obo/CHEBI_29991|http://purl.obolibrary.org/obo/CHEBI_29993 |
| T69299 | 245-254 | Chemical | denotes | aspartate | http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314 |
| T96973 | 278-285 | Chemical | denotes | alanine | http://purl.obolibrary.org/obo/CHEBI_16449 |
| T33547 | 290-304 | Chemical | denotes | carbon dioxide | http://purl.obolibrary.org/obo/CHEBI_16526 |
| T30476 | 290-296 | Chemical | denotes | carbon | http://purl.obolibrary.org/obo/CHEBI_27594|http://purl.obolibrary.org/obo/CHEBI_33415 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 838 | 315-341 | Species | denotes | Mycobacterium tuberculosis | Tax:1773 |
| 839 | 160-171 | Chemical | denotes | L-Aspartate | MESH:D001224 |
| 840 | 243-254 | Chemical | denotes | L-aspartate | MESH:D001224 |
| 841 | 276-285 | Chemical | denotes | β-alanine | MESH:D015091 |
| 842 | 290-304 | Chemical | denotes | carbon dioxide | MESH:D002245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T549 | 0-342 | Sentence | denotes | NMR by itself is a powerful tool for drug validation as in the case of Sharma et al. (2012) [370] who sought to identify potential drug-like inhibitors against L-Aspartate α-Decarboxylase (ADC) an enzyme responsible for the decarboxylation of L-aspartate in order to generate β-alanine and carbon dioxide [371], in Mycobacterium tuberculosis. |